Shire plc News Headlines

SHPG 
$194.49
*  
9.51
5.14%
Get SHPG Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading SHPG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Salix's Rectal Foam Uceris Receives Final FDA Approval - Analyst Blog
10/9/2014 6:30:00 PM - Zacks.com


Astellas' New Data on Cresemba for Invasive Mucormycosis - Analyst Blog
10/9/2014 5:30:00 PM - Zacks.com


Heat Biologics Completes Dosing for Vesigenurtacel-L Trial - Analyst Blog
10/9/2014 3:54:00 PM - Zacks.com


FDA Says Addnl. Pediatric Data Required For Shire's Resubmission Of SHP 465 NDA
10/9/2014 5:00:00 AM - RTT News


Alcobra Reveals ADHD Top-line Phase III Data, Shares Down - Analyst Blog
10/8/2014 2:28:00 PM - Zacks.com


Strength Seen in Alcobra (ADHD): Stock Rises 6.4% - Tale of the Tape
10/8/2014 9:25:00 AM - Zacks.com


Novartis Collaborates with Bristol-Myers Squibb - Analyst Blog
10/7/2014 4:50:00 PM - Zacks.com


Sunesis Pharmaceuticals Down on Failure of Trial on Qinprezo - Analyst Blog
10/7/2014 4:40:00 PM - Zacks.com


I Was Inverted With Shire
10/7/2014 7:30:00 AM - Seeking Alpha


Better Dividend Stock: Amgen, Inc. or AbbVie Inc.?
10/6/2014 9:51:02 AM - Motley Fool


Ardelyx (ARDX) Worth Watching: Stock Moves 16% Higher - Tale of the Tape
10/6/2014 9:46:00 AM - Zacks.com


Jazz Pharmaceuticals Uses New Cash To Buy For Growth
10/3/2014 2:39:00 PM - Investor's Business Daily


Achillion: Positioned To Deliver The Last Clinical Stage Nuc To The Highest Bidder
10/2/2014 2:48:00 PM - Seeking Alpha


Overpriced Expectations: Alcobra Will Get To Second Base, But No Home Run. Options Are Mispriced For An Unlikely Event
9/30/2014 3:03:00 PM - Seeking Alpha


Valeant's Bausch + Lomb Announces Results on Lotemax - Analyst Blog
9/30/2014 12:10:00 PM - Zacks.com


Roche Releases Data from CLEOPATRA Study on Perjeta - Analyst Blog
9/29/2014 4:50:00 PM - Zacks.com


Why AbbVie (ABBV) Stock Is Up Today
9/26/2014 11:30:00 AM - TheStreet


3 Reasons AbbVie Inc Stock Could Fall
9/26/2014 10:17:13 AM - Motley Fool


Shire Resolves Litigation Related to Vyvanse, Adderall XR - Analyst Blog
9/25/2014 5:20:00 PM - Zacks.com


European Stock Futures Signal Flat To Positive Start
9/25/2014 2:17:00 AM - RTT News


OPKO Health (OPK) Reports Positive Data on Rayaldee Trial - Analyst Blog
9/24/2014 4:36:00 PM - Zacks.com


Shire To Pay About $57 Mln To Resolve Issues With US Govt. - Quick Facts
9/24/2014 4:15:00 PM - RTT News


Will New Treasury Rules Contain Tax Inversions? - Analyst Blog
9/24/2014 10:22:00 AM - Zacks.com


Stock Market News for September 24, 2014 - Market News
9/24/2014 10:10:00 AM - Zacks.com


3 Top Dividend Growth Stocks to Buy in October
9/24/2014 8:37:07 AM - Motley Fool